Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.
D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use; D001770:Blood Bactericidal Activity; D005260:Female; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000517:prevention & control; D009345:Neisseria meningitidis / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000592:standards* / Q000627:therapeutic use; D011863:Radioimmunoassay
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial